Circulating tumour cells in patients with lung cancer undergoing endobronchial cryotherapy

Dimple Chudasama, Alexandra Rice, Gopal Soppa, Vladimir Anikin*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)


Early diagnosis of lung cancer still poses a major issue, with a large proportion of patients diagnosed at late stages. Therapeutic options and treatment remain limited in these patients. In most cases only palliative therapies are available to alleviate any severe symptoms. Endobronchial cryotherapy (EC) is one form of palliative treatment offered to patients with obstructive airway tumours. Although successful, the impact on circulating tumour cell (CTCs) spread has not been investigated in detail. This study recruited 20 patients awaiting EC treatment. Baseline and post EC blood samples were analysed for presence of CTCs. Results showed an increase in CTCs following EC in 75% of patients. Significant increases were noticeable in some cases. Although EC is a well-accepted modality of treatment to alleviate symptoms, it may lead to an increase in CTCs, which in turn may have implications for tumour dissemination and metastatic spread.

Original languageEnglish
Pages (from-to)161-163
Number of pages3
Issue number1
Publication statusPublished - 1 Aug 2015
Externally publishedYes

Bibliographical note

Funding Information:
This study has been funded by the Cryotherapy Research Charity (Fund Number G0029 ).

Publisher Copyright:
© 2015 Elsevier Inc.


  • Circulating tumour cells
  • Endobronchial cryotherapy
  • Endobronchial tumours
  • ScreenCell


Dive into the research topics of 'Circulating tumour cells in patients with lung cancer undergoing endobronchial cryotherapy'. Together they form a unique fingerprint.

Cite this